SCHEMBL8417837

SCHEMBL8417837

COc1ccc(Br)cc1C(=O)NC1(C)CCN(CCCOc2ccc(F)cc2)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.45
DRD3 P35462 4/20 0.45
CYP3A4 P08684 3/20 0.45
CYP2D6 P10635 3/20 0.45
HTR4 Q13639 3/20 0.45
DRD2 P14416 3/20 0.45
CYP2C9 P11712 2/20 0.45
HTR1A P08908 2/20 0.45
DRD1 P21728 2/20 0.45
HTR2A P28223 2/20 0.45
SLC6A4 P31645 2/20 0.45
HTR7 P34969 2/20 0.45
HRH1 P35367 2/20 0.45
HTR2B P41595 2/20 0.45
SIGMAR1 Q99720 2/20 0.45
USP2 O75604 1/20 0.45
HTR3E A5X5Y0 1/20 0.45
MLNR O43193 1/20 0.45
CACNA1F O60840 1/20 0.45
HTR3B O95264 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8416209 0.89 KCNH2 (0.45) KCNH2DRD3CYP3A4CYP2D6HTR4
SCHEMBL8417804 0.88 DRD3 (0.50) KCNH2DRD3CYP2D6DRD2HTR1A
SCHEMBL8865738 0.87 KCNH2 (0.52) KCNH2DRD3CYP3A4CYP2D6HTR4
SCHEMBL8866468 0.84 KCNH2 (0.48) KCNH2DRD3CYP3A4CYP2D6HTR4
SCHEMBL8865630 0.83 HTR4 (0.52) KCNH2DRD3CYP3A4CYP2D6HTR4
SCHEMBL8866229 0.83 HTR4 (0.64) KCNH2DRD3CYP3A4CYP2D6HTR4
SCHEMBL29904381 0.83 HTR4 (0.52) KCNH2DRD3CYP3A4CYP2D6HTR4
Water SCHEMBL7130515 0.83 KCNH2 (0.49) KCNH2DRD3CYP3A4CYP2D6HTR4
SCHEMBL8414975 0.82 ALDH1A1 (0.50) DRD2HTR2AHTR2BHTR2CL3MBTL1
SCHEMBL8415110 0.78 HTR2A (0.54) DRD3CYP2D6DRD2HTR1ADRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0650475-B1 4-AMINO-N-(4-METHYL-4-PIPERIDINYL)-2-METHOXYBENZAMIDES, THEIR PREPARATION AND THEIR USE AS 5-HT2 ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 1999-09-01 EP disclosed